1 “... effectiveness and safety of this treatment for moderate to severe plaque psoriasis in adults...”

2 “... effectiveness and safety of this treatment for moderate to severe plaque psoriasis in adults...”

3 “... of intravenous propofol and remifentanil administered by independent TCI pumps for patients undergoing moderate...”

4

5

6 “... effects of dupilumab (Dupixent) for the treatment of adult patients with moderate-to-severe atopic...”

7 “... effects of dupilumab (Dupixent) for the treatment of adult patients with moderate-to-severe atopic...”

8 “...Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who...”

9 “...Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who...”

10 “... for the treatment of moderate to severe plaque psoriasis in adults only if the following conditions are met: In a...”

11 “... to patients with moderate-to-severe plaque psoriasis, who are likely to be concurrently on systemic...”

12 “.... In clinical trials, moderate-tosevere psoriasis is defined by a lower limit of 10% BSA and the same limits...”

13 “... for patients with moderate to severe plaque psoriasis...”

14 “... for patients with moderate to severe plaque psoriasis...”

15 “... in adult patients with moderate-to severe plaque psoriasis. HP/TAZ is a combination product composed of a...”

16 “...Clinical evidence suggests that Ilumya should be reimbursed to treat patients with moderate...”

17 “...indication : for the treatment of adult patients with moderately to severely active ulcerative...”

18 “... subcutaneous injection at recommended doses for the treatment of adult patients with moderately to severely...”

19 “... tumour necrosis factor alpha that is indicated for the treatment of adult patients with moderate...”

20 “... for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy...”